Comparison of Bowel Cleansing Regimens Prior to Colonoscopy

NCT ID: NCT01649674

Last Updated: 2023-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

525 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to to compare two bowel preparation regimens of patients who will undergo colonoscopy, in terms of quality of bowel preparation and in terms of patient satisfaction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patients Undergoing Elective Colonoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PEG

polyethylene glycol solution 2 liters

Group Type ACTIVE_COMPARATOR

polyethylene glycole (PEG) solution

Intervention Type DRUG

NapP

Sodium picosulphate and magnesium citrate solution 300 ml

Group Type ACTIVE_COMPARATOR

sodium picosulphate and magnesium citrate solution

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

polyethylene glycole (PEG) solution

Intervention Type DRUG

sodium picosulphate and magnesium citrate solution

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Subjects who are candidate to undergo colonoscopy: Diagnosis Screening Follow-up after previous polypectomy

* Informed consent
* Age \> 18 years

Exclusion Criteria

* Previous colonic resection
* Severe inflammatory bowel disease (IBD)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute, Naples

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Valentina D'Angelo, M.D.

Role: PRINCIPAL_INVESTIGATOR

National Cancer Institute, Naples

Mario de Bellis, M.D.

Role: PRINCIPAL_INVESTIGATOR

National Cancer Institute, Naples

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Presidio Ospedaliero Villa d'Agri

Marsicovetere, , Italy

Site Status

AO Fatebenefratelli ed Oftalmico

Milan, , Italy

Site Status

A.O.U. Seconda Universita di Napoli

Napoli, , Italy

Site Status

Clinica Mediterranea

Napoli, , Italy

Site Status

Istituto Nazionale dei Tumori

Napoli, , Italy

Site Status

Presidio Ospedaliero Ascalesi

Napoli, , Italy

Site Status

Presidio Ospedaliero Maresca

Torre del Greco, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

D'Angelo V, Piccirillo MC, Di Maio M, Gallo C, Bucci C, Civiletti C, Di Girolamo E, Marone P, Rossi GB, Tempesta AM, Tracey MC, Romano M, Miranda A, Taranto D, Sessa G, Esposito P, Salerno R, Pumpo R, De Filippo FR, Della Valle E, de Bellis M, Perrone F. A multicenter randomized phase 4 trial comparing sodium picosulphate plus magnesium citrate vs. polyethylene glycol plus ascorbic acid for bowel preparation before colonoscopy. The PRECOL trial. Front Med (Lausanne). 2022 Dec 8;9:1013804. doi: 10.3389/fmed.2022.1013804. eCollection 2022.

Reference Type DERIVED
PMID: 36569131 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-000587-10

Identifier Type: REGISTRY

Identifier Source: secondary_id

PRECOL2011-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multi-centre Failed Bowel Prep RCT
NCT02976805 COMPLETED PHASE3
PMC Split Preparation for Colon Cleansing
NCT01909219 COMPLETED PHASE4
MOVIPREP® Versus PICOLAX® Pilot Study
NCT00312481 COMPLETED PHASE2